866-997-4948(US-Canada Toll Free)

Global and United States Estrogen and Progesterone In-Depth Research Report 2017-2022

Published By :

US Market Insight

Published Date : Aug 2017

Category :

Pharmaceutical

No. of Pages : 112 Pages

The report is based on the market historical data from 2012 to 2016 and forecast the market trend from 2017 to 2022.

This report focuses on the U.S. market and presents volume and value of market share by players, by regions, by product type, by consumers and also changes in prices. As an in-depth report, it covers all details inside analysis and opinions in Estrogen and Progesterone industry.

Major Companies
Gedeon Richter Plc.
Bayer Oy
N.V.Organon
Pfizer Healthcare Ireland
Jenapharm GmbH & Co. KG
Besins Healthcare Benelux
MERCK SERONO LIMITED
Abbott Healthcare Products B.V.
Teva Pharma - Produtos Farmaceuticos,Lda.
Aspen Pharmacare Australia Pty Ltd.
Dr.Kade Pharmazeutische Fabrik GmbH
F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.
Eli Lilly Nederland B.V
Orion Corporation
AstraZeneca UK Limited
Novartis Pharma Schweiz AG

Key Regions
North America
United States
California
Texas
New York
Others
Canada
Latin America
Mexico
Brazil
Argentina
Others
Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherland
Others
Asia & Pacific
China
Japan
India
Korea
Australia
Southeast Asia
Indonesia
Thailand
Philippines
Vietnam
Singapore
Malaysia
Others
Africa & Middle East
South Africa
Egypt
Turkey
Saudi Arabia
Iran
Others

Main Product Type
Estrogen and Progesterone Market, by Progesterone stimulant
Norethisterone Acetate
Ethynodiol diacetate
Levonorgestrel
Methylnorethindrone
Norelgestromin
Desogestrel
Etonogestrel
Gestodene
Norgestimate
Drospirenone
Nomegestrol
Promegestone
Trimegestone
Dienogest
chlormadinone
cyproterine
Medroxyprogesterone acetate
megestrol
Gestonorone
anhydrohydroxy progesterone
Medrogestone
Norgestrienone
Lynestrenol
Norethynodrel
Tibolone
Dydrogesterone
Quingestanol
Estrogen and Progesterone Market, by Antiprogestogen
Aglepristone
Mifepristone
Asoprisnil
Telapristone
Ulipristal acetate
Estrogen and Progesterone Market, by Estrogenic stimulant
Megestrol
Estradiol
Estradiol Acetate
Estradiol Benzoate
estradiol cypionate
Estradiol Dipropionate
Estradiol enanthate
Estradiol Undecylate
Estradiol valerate
Polyestradiol phosphate
Estriol Triacetate
Piperazine Estrone
Ethinyl estradiol
Mestranol
Promestriene
Equilenin
Equilin
Chlorotrianisene
Dienoestrol
Fosfestrol
Diethylstilbestrol
Zeranol
Estrogen and Progesterone Market, by Antiestrogen agent
Afimoxifene
Arzoxifene
Bazedoxifene
Clomifene
Cyclofenil
Epimestrol
Lasofoxifene
Mepitiostane
Nafoxidine
Ormeloxifene
Raloxifene
Tamoxifen
Toremifene
Fulvestrant
Estrogen and Progesterone Market, by Aromatase Inhibitor
Aminoglutethimide
Testolactone
Anastrozole
Atamestane
Exemestane
Fadrozole
Formestane
Letrozole
Minamestane
Plomestane
Vorozole

Main Applications
Pharmacy
Hospital
Department of endocrinology


Table of Contents



Global and United States Estrogen and Progesterone In-Depth Research Report 2017-2022

Chapter One Global Estrogen and Progesterone Market Overview

1.1 Global Estrogen and Progesterone Market Sales Volume Revenue and Price 2012-2017

1.2 Estrogen and Progesterone, by Progesterone stimulant 2012-2017

1.2.1 Global Estrogen and Progesterone Sales Market Share by Progesterone stimulant 2012-2017

1.2.2 Global Estrogen and Progesterone Revenue Market Share by Progesterone stimulant 2012-2017

1.2.3 Global Estrogen and Progesterone Price by Progesterone stimulant 2012-2017

1.3 Estrogen and Progesterone, by Antiprogestogen 2012-2017

1.3.1 Global Estrogen and Progesterone Sales Market Share by Antiprogestogen 2012-2017

1.3.2 Global Estrogen and Progesterone Revenue Market Share by Antiprogestogen 2012-2017

1.3.3 Global Estrogen and Progesterone Price by Antiprogestogen 2012-2017

1.4 Estrogen and Progesterone, by Estrogenic stimulant 2012-2017

1.4.1 Global Estrogen and Progesterone Sales Market Share by Estrogenic stimulant 2012-2017

1.4.2 Global Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant 2012-2017

1.4.3 Global Estrogen and Progesterone Price by Estrogenic stimulant 2012-2017

1.5 Estrogen and Progesterone, by Antiestrogen agent 2012-2017

1.5.1 Global Estrogen and Progesterone Sales Market Share by Antiestrogen agent 2012-2017

1.5.2 Global Estrogen and Progesterone Revenue Market Share by Antiestrogen agent 2012-2017

1.5.3 Global Estrogen and Progesterone Price by Antiestrogen agent 2012-2017

1.6 Estrogen and Progesterone, by Aromatase Inhibitor 2012-2017

1.6.1 Global Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor 2012-2017

1.6.2 Global Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor 2012-2017

1.6.3 Global Estrogen and Progesterone Price by Aromatase Inhibitor 2012-2017



Chapter Two United States Estrogen and Progesterone Market Overview

2.1 United States Estrogen and Progesterone Market Sales Volume Revenue and Price 2012-2017

2.2 Estrogen and Progesterone, by Progesterone stimulant 2012-2017

2.2.1 United States Estrogen and Progesterone Sales Market Share by Progesterone stimulant 2012-2017

2.2.2 United States Estrogen and Progesterone Revenue Market Share by Progesterone stimulant 2012-2017

2.2.3 United States Estrogen and Progesterone Price by Progesterone stimulant 2012-2017

2.3 Estrogen and Progesterone, by Antiprogestogen 2012-2017

2.3.1 United States Estrogen and Progesterone Sales Market Share by Antiprogestogen 2012-2017

2.3.2 United States Estrogen and Progesterone Revenue Market Share by Antiprogestogen 2012-2017

2.3.3 United States Estrogen and Progesterone Price by Antiprogestogen 2012-2017

2.4 Estrogen and Progesterone, by Estrogenic stimulant 2012-2017

2.4.1 United States Estrogen and Progesterone Sales Market Share by Estrogenic stimulant 2012-2017

2.4.2 United States Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant 2012-2017

2.4.3 United States Estrogen and Progesterone Price by Estrogenic stimulant 2012-2017

2.5 Estrogen and Progesterone, by Antiestrogen agent 2012-2017

2.5.1 United States Estrogen and Progesterone Sales Market Share by Antiestrogen agent 2012-2017

2.5.2 United States Estrogen and Progesterone Revenue Market Share by Antiestrogen agent 2012-2017

2.5.3 United States Estrogen and Progesterone Price by Antiestrogen agent 2012-2017

2.6 Estrogen and Progesterone, by Aromatase Inhibitor 2012-2017

2.6.1 United States Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor 2012-2017

2.6.2 United States Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor 2012-2017

2.6.3 United States Estrogen and Progesterone Price by Aromatase Inhibitor 2012-2017



Chapter Three Estrogen and Progesterone by Regions 2012-2017

3.1 Global Estrogen and Progesterone Sales Market Share by Regions 2012-2017

3.2 Global Estrogen and Progesterone Revenue Market Share by Regions 2012-2017

3.3 Global Estrogen and Progesterone Price by Regions 2012-2017

3.4 North America

3.4.1 United States

3.4.1.1 California

3.4.1.2 Texas

3.4.1.3 New York

3.4.1.4 Others in United States

3.4.2 Canada

3.5 Latin America

3.5.1 Mexico

3.5.2 Brazil

3.5.3 Argentina

3.5.4 Others in Latin America

3.6 Europe

3.6.1 Germany

3.6.2 United Kingdom

3.6.3 France

3.6.4 Italy

3.6.5 Spain

3.6.6 Russia

3.6.7 Netherland

3.6.8 Others in Europe

3.7 Asia & Pacific

3.7.1 China

3.7.2 Japan

3.7.3 India

3.7.4 Korea

3.7.5 Australia

3.7.6 Southeast Asia

3.7.6.1 Indonesia

3.7.6.2 Thailand

3.7.6.3 Philippines

3.7.6.4 Vietnam

3.7.6.5 Singapore

3.7.6.6 Malaysia

3.7.6.7 Others in Southeast Asia

3.8 Africa & Middle East

3.8.1 South Africa

3.8.2 Egypt

3.8.3 Turkey

3.8.4 Saudi Arabia

3.8.5 Iran

3.8.6 Others in Africa & Middle East



Chapter Four Global Estrogen and Progesterone by Companies 2012-2017

4.1 Global Estrogen and Progesterone Sales Volume Market Share by Companies 2012-2017

4.2 Global Estrogen and Progesterone Revenue Share by Companies 2012-2017

4.3 Global Top Companies Estrogen and Progesterone Key Product Model and Market Performance

4.4 Global Top Companies Estrogen and Progesterone Key Target Consumers and Market Performance



Chapter Five United States Estrogen and Progesterone by Companies 2012-2017

5.1 United States Estrogen and Progesterone Sales Volume Market Share by Companies 2012-2017

5.2 United States Estrogen and Progesterone Revenue Share by Companies 2012-2017

5.3 United States Top Companies Estrogen and Progesterone Key Product Model and Market Performance

5.4 United States Top Companies Estrogen and Progesterone Key Target Consumers and Market Performance



Chapter Six Global Estrogen and Progesterone by Consumer 2012-2017

6.1 Global Estrogen and Progesterone Sales Market Share by Consumer 2012-2017

6.2

6.3

6.2 Consuming Habit and Preference



Chapter Seven Global Estrogen and Progesterone by Consumer 2012-2017

7.1 Global Estrogen and Progesterone Sales Market Share by Consumer 2012-2017

7.2

7.3

7.2 Consuming Habit and Preference



Chapter Eight Top Companies Profile

8.1 Gedeon Richter Plc.

8.1.1 Gedeon Richter Plc. Company Details and Competitors

8.1.2 Gedeon Richter Plc. Key Estrogen and Progesterone Models and Performance

8.1.3 Gedeon Richter Plc. Estrogen and Progesterone Business SWOT Analysis and Forecast

8.1.4 Gedeon Richter Plc. Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.2 Bayer Oy

8.2.1 Bayer Oy Company Details and Competitors

8.2.2 Bayer Oy Key Estrogen and Progesterone Models and Performance

8.2.3 Bayer Oy Estrogen and Progesterone Business SWOT Analysis and Forecast

8.2.4 Bayer Oy Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.3 N.V.Organon

8.3.1 N.V.Organon Company Details and Competitors

8.3.2 N.V.Organon Key Estrogen and Progesterone Models and Performance

8.3.3 N.V.Organon Estrogen and Progesterone Business SWOT Analysis and Forecast

8.3.4 N.V.Organon Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.4 Pfizer Healthcare Ireland

8.4.1 Pfizer Healthcare Ireland Company Details and Competitors

8.4.2 Pfizer Healthcare Ireland Key Estrogen and Progesterone Models and Performance

8.4.3 Pfizer Healthcare Ireland Estrogen and Progesterone Business SWOT Analysis and Forecast

8.4.4 Pfizer Healthcare Ireland Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.5 Jenapharm GmbH & Co. KG

8.5.1 Jenapharm GmbH & Co. KG Company Details and Competitors

8.5.2 Jenapharm GmbH & Co. KG Key Estrogen and Progesterone Models and Performance

8.5.3 Jenapharm GmbH & Co. KG Estrogen and Progesterone Business SWOT Analysis and Forecast

8.5.4 Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.6 Besins Healthcare Benelux

8.6.1 Besins Healthcare Benelux Company Details and Competitors

8.6.2 Besins Healthcare Benelux Key Estrogen and Progesterone Models and Performance

8.6.3 Besins Healthcare Benelux Estrogen and Progesterone Business SWOT Analysis and Forecast

8.6.4 Besins Healthcare Benelux Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.7 MERCK SERONO LIMITED

8.7.1 MERCK SERONO LIMITED Company Details and Competitors

8.7.2 MERCK SERONO LIMITED Key Estrogen and Progesterone Models and Performance

8.7.3 MERCK SERONO LIMITED Estrogen and Progesterone Business SWOT Analysis and Forecast

8.7.4 MERCK SERONO LIMITED Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.8 Abbott Healthcare Products B.V.

8.8.1 Abbott Healthcare Products B.V. Company Details and Competitors

8.8.2 Abbott Healthcare Products B.V. Key Estrogen and Progesterone Models and Performance

8.8.3 Abbott Healthcare Products B.V. Estrogen and Progesterone Business SWOT Analysis and Forecast

8.8.4 Abbott Healthcare Products B.V. Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.9 Teva Pharma - Produtos Farmaceuticos,Lda.

8.9.1 Teva Pharma - Produtos Farmaceuticos,Lda. Company Details and Competitors

8.9.2 Teva Pharma - Produtos Farmaceuticos,Lda. Key Estrogen and Progesterone Models and Performance

8.9.3 Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Business SWOT Analysis and Forecast

8.9.4 Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.10 Aspen Pharmacare Australia Pty Ltd.

8.10.1 Aspen Pharmacare Australia Pty Ltd. Company Details and Competitors

8.10.2 Aspen Pharmacare Australia Pty Ltd. Key Estrogen and Progesterone Models and Performance

8.10.3 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Business SWOT Analysis and Forecast

8.10.4 Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales Volume Revenue Price Cost and Gross Margin

8.11 Dr.Kade Pharmazeutische Fabrik GmbH

8.12 F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A.

8.13 Eli Lilly Nederland B.V

8.14 Orion Corporation

8.15 AstraZeneca UK Limited

8.16 Novartis Pharma Schweiz AG



Chapter Nine Industry Chain and Supply Chain

9.1 Estrogen and Progesterone Industry Chain Structure

9.1.1 R&D

9.1.2 Raw Materials (Components)

9.1.3 Manufacturing Plants

9.1.4 Regional Trading (Import Export and Local Sales)

9.1.5 Online Sales Channel

9.1.6 Offline Channel

9.1.7 End Users

9.2 Estrogen and Progesterone Manufacturing

9.2.1 Key Components

9.2.2 Assembly Manufacturing

9.3 Consumer Preference

9.4 Behavioral Habits

9.5 Marketing Environment



Chapter Ten Global Estrogen and Progesterone Market Size (Sales and Revenue) Forecast (2017-2022)

10.1 Global Estrogen and Progesterone Sales (), Revenue (Million USD) Forecast (2017-2022)

10.2 Global Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)

10.3 Global Estrogen and Progesterone Sales () Forecast by Application (2017-2022)

10.4 Global Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)

10.5 Global Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)

10.6 Global Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)

10.7 Global Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)

10.8 Global Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)



Chapter Eleven United States Estrogen and Progesterone Market Size (Sales and Revenue) Forecast (2017-2022)

11.1 United States Estrogen and Progesterone Sales (), Revenue (Million USD) Forecast (2017-2022)

11.2 United States Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)

11.3 United States Estrogen and Progesterone Sales () Forecast by Application (2017-2022)

11.4 United States Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)

11.5 United States Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)

11.6 United States Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)

11.7 United States Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)

11.8 United States Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)



Chapter Twelve Development Trend and Research Conclusion

12.1 Development Trend

12.2 Research Conclusion



Chapter Thirteen Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer





List of Table

List of Tables and Figures



Table Global Estrogen and Progesterone Sales Volume (), Revenue (Million USD) and Price ()(2012-2017)

Figure Global Estrogen and Progesterone Revenue (Million USD) and Growth Rate (2012-2017)

Figure Global Estrogen and Progesterone Sales Volume () and Growth Rate (2012-2017)

Table Global Estrogen and Progesterone Sales () by Progesterone stimulant (2012-2017)

Table Global Estrogen and Progesterone Sales Market Share by Progesterone stimulant (2012-2017)

Figure Global Estrogen and Progesterone Sales Market Share by Progesterone stimulant in 2016

Table Global Estrogen and Progesterone Revenue (Million USD) by Progesterone stimulant (2012-2017)

Table Global Estrogen and Progesterone Revenue Market Share by Progesterone stimulant (2012-2017)

Figure Global Estrogen and Progesterone Revenue Market Share by Progesterone stimulant in 2016

Table Global Estrogen and Progesterone Price () by Progesterone stimulant (2012-2017)

Table Top Companies of Norethisterone Acetate Estrogen and Progesterone Products List

Figure Global Norethisterone Acetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Ethynodiol diacetate Estrogen and Progesterone Products List

Figure Global Ethynodiol diacetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Global Estrogen and Progesterone Sales () by Antiprogestogen (2012-2017)

Table Global Estrogen and Progesterone Sales Market Share by Antiprogestogen (2012-2017)

Figure Global Estrogen and Progesterone Sales Market Share by Antiprogestogen in 2016

Table Global Estrogen and Progesterone Revenue (Million USD) by Antiprogestogen (2012-2017)

Table Global Estrogen and Progesterone Revenue Market Share by Antiprogestogen (2012-2017)

Figure Global Estrogen and Progesterone Revenue Market Share by Antiprogestogen in 2016

Table Global Estrogen and Progesterone Price () by Antiprogestogen (2012-2017)

Table Top Companies of Aglepristone Estrogen and Progesterone Products List

Figure Global Aglepristone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Mifepristone Estrogen and Progesterone Products List

Figure Global Mifepristone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Global Estrogen and Progesterone Sales () by Estrogenic stimulant (2012-2017)

Table Global Estrogen and Progesterone Sales Market Share by Estrogenic stimulant (2012-2017)

Figure Global Estrogen and Progesterone Sales Market Share by Estrogenic stimulant in 2016

Table Global Estrogen and Progesterone Revenue (Million USD) by Estrogenic stimulant (2012-2017)

Table Global Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant (2012-2017)

Figure Global Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant in 2016

Table Global Estrogen and Progesterone Price () by Estrogenic stimulant (2012-2017)

Table Top Companies of Megestrol Estrogen and Progesterone Products List

Figure Global Megestrol Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Estradiol Estrogen and Progesterone Products List

Figure Global Estradiol Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Estradiol Acetate Estrogen and Progesterone Products List

Figure Global Estradiol Acetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Global Estrogen and Progesterone Sales () by Antiestrogen agent (2012-2017)

Table Global Estrogen and Progesterone Sales Market Share by Antiestrogen agent (2012-2017)

Figure Global Estrogen and Progesterone Sales Market Share by Antiestrogen agent in 2016

Table Global Estrogen and Progesterone Revenue (Million USD) by Antiestrogen agent (2012-2017)

Table Global Estrogen and Progesterone Revenue Market Share by Antiestrogen agent (2012-2017)

Figure Global Estrogen and Progesterone Revenue Market Share by Antiestrogen agent in 2016

Table Global Estrogen and Progesterone Price () by Antiestrogen agent (2012-2017)

Table Top Companies of Afimoxifene Estrogen and Progesterone Products List

Figure Global Afimoxifene Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Arzoxifene Estrogen and Progesterone Products List

Figure Global Arzoxifene Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Global Estrogen and Progesterone Sales () by Aromatase Inhibitor (2012-2017)

Table Global Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor (2012-2017)

Figure Global Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor in 2016

Table Global Estrogen and Progesterone Revenue (Million USD) by Aromatase Inhibitor (2012-2017)

Table Global Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor (2012-2017)

Figure Global Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor in 2016

Table Global Estrogen and Progesterone Price () by Aromatase Inhibitor (2012-2017)

Table Top Companies of Aminoglutethimide Estrogen and Progesterone Products List

Figure Global Aminoglutethimide Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Testolactone Estrogen and Progesterone Products List

Figure Global Testolactone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Figure United States Estrogen and Progesterone Revenue (Million USD) and Growth Rate (2012-2017)

Figure United States Estrogen and Progesterone Sales Volume () and Growth Rate (2012-2017)

Table United States Estrogen and Progesterone Sales () by Progesterone stimulant (2012-2017)

Table United States Estrogen and Progesterone Sales Market Share by Progesterone stimulant (2012-2017)

Figure United States Estrogen and Progesterone Sales Market Share by Progesterone stimulant in 2016

Table United States Estrogen and Progesterone Revenue (Million USD) by Progesterone stimulant (2012-2017)

Table United States Estrogen and Progesterone Revenue Market Share by Progesterone stimulant (2012-2017)

Figure United States Estrogen and Progesterone Revenue Market Share by Progesterone stimulant in 2016

Table United States Estrogen and Progesterone Price () by Progesterone stimulant (2012-2017)

Table Top Companies of Norethisterone Acetate Estrogen and Progesterone Products List

Figure United States Norethisterone Acetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Ethynodiol diacetate Estrogen and Progesterone Products List

Figure United States Ethynodiol diacetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table United States Estrogen and Progesterone Sales () by Antiprogestogen (2012-2017)

Table United States Estrogen and Progesterone Sales Market Share by Antiprogestogen (2012-2017)

Figure United States Estrogen and Progesterone Sales Market Share by Antiprogestogen in 2016

Table United States Estrogen and Progesterone Revenue (Million USD) by Antiprogestogen (2012-2017)

Table United States Estrogen and Progesterone Revenue Market Share by Antiprogestogen (2012-2017)

Figure United States Estrogen and Progesterone Revenue Market Share by Antiprogestogen in 2016

Table United States Estrogen and Progesterone Price () by Antiprogestogen (2012-2017)

Table Top Companies of Aglepristone Estrogen and Progesterone Products List

Figure United States Aglepristone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Mifepristone Estrogen and Progesterone Products List

Figure United States Mifepristone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table United States Estrogen and Progesterone Sales () by Estrogenic stimulant (2012-2017)

Table United States Estrogen and Progesterone Sales Market Share by Estrogenic stimulant (2012-2017)

Figure United States Estrogen and Progesterone Sales Market Share by Estrogenic stimulant in 2016

Table United States Estrogen and Progesterone Revenue (Million USD) by Estrogenic stimulant (2012-2017)

Table United States Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant (2012-2017)

Figure United States Estrogen and Progesterone Revenue Market Share by Estrogenic stimulant in 2016

Table United States Estrogen and Progesterone Price () by Estrogenic stimulant (2012-2017)

Table Top Companies of Megestrol Estrogen and Progesterone Products List

Figure United States Megestrol Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Estradiol Estrogen and Progesterone Products List

Figure United States Estradiol Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Estradiol Acetate Estrogen and Progesterone Products List

Figure United States Estradiol Acetate Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table United States Estrogen and Progesterone Sales () by Antiestrogen agent (2012-2017)

Table United States Estrogen and Progesterone Sales Market Share by Antiestrogen agent (2012-2017)

Figure United States Estrogen and Progesterone Sales Market Share by Antiestrogen agent in 2016

Table United States Estrogen and Progesterone Revenue (Million USD) by Antiestrogen agent (2012-2017)

Table United States Estrogen and Progesterone Revenue Market Share by Antiestrogen agent (2012-2017)

Figure United States Estrogen and Progesterone Revenue Market Share by Antiestrogen agent in 2016

Table United States Estrogen and Progesterone Price () by Antiestrogen agent (2012-2017)

Table Top Companies of Afimoxifene Estrogen and Progesterone Products List

Figure United States Afimoxifene Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Arzoxifene Estrogen and Progesterone Products List

Figure United States Arzoxifene Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table United States Estrogen and Progesterone Sales () by Aromatase Inhibitor (2012-2017)

Table United States Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor (2012-2017)

Figure United States Estrogen and Progesterone Sales Market Share by Aromatase Inhibitor in 2016

Table United States Estrogen and Progesterone Revenue (Million USD) by Aromatase Inhibitor (2012-2017)

Table United States Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor (2012-2017)

Figure United States Estrogen and Progesterone Revenue Market Share by Aromatase Inhibitor in 2016

Table United States Estrogen and Progesterone Price () by Aromatase Inhibitor (2012-2017)

Table Top Companies of Aminoglutethimide Estrogen and Progesterone Products List

Figure United States Aminoglutethimide Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Top Companies of Testolactone Estrogen and Progesterone Products List

Figure United States Testolactone Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Global Estrogen and Progesterone Sales () by Regions (2012-2017)

Table Global Estrogen and Progesterone Sales Share by Regions (2012-2017)

Figure Global Estrogen and Progesterone Sales Market Share by Regions in 2016

Figure Global Estrogen and Progesterone Sales Market Share by Regions in 2017

Table Global Estrogen and Progesterone Revenue (Million USD) and Market Share by Regions (2012-2017)

Table Global Estrogen and Progesterone Revenue Market Share by Regions (2012-2017)

Figure Global Estrogen and Progesterone Revenue Market Share by Regions in 2016

Figure Global Estrogen and Progesterone Revenue Market Share by Regions in 2017

Table Global Estrogen and Progesterone Price () by Regions (2012-2017)

Table North America Estrogen and Progesterone Sales () by Regions (2012-2017)

Table North America Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)

Figure North America Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table United States Estrogen and Progesterone Sales () by Regions (2012-2017)

Table United States Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)

Figure United States Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Latin America Estrogen and Progesterone Sales () by Regions (2012-2017)

Table Latin America Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)

Figure Latin America Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Europe Estrogen and Progesterone Sales () by Regions (2012-2017)

Table Europe Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)

Figure Europe Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Asia & Pacific Estrogen and Progesterone Sales () by Regions (2012-2017)

Table Asia & Pacific Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)

Figure Asia & Pacific Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Africa & Middle East Estrogen and Progesterone Sales () by Regions (2012-2017)

Table Africa & Middle East Estrogen and Progesterone Revenue (Million USD) by Regions (2012-2017)

Figure Africa & Middle East Estrogen and Progesterone Sales () and Growth Rate (2012-2017)

Table Global Estrogen and Progesterone Sales Volume () by Major Companies (2012-2017)

Table Global Estrogen and Progesterone Sales Volume Market Share by Major Companies (2012-2017)

Figure Global Estrogen and Progesterone Sales Volume Market Share by Major Companies 2016

Figure Global Estrogen and Progesterone Sales Volume Market Share by Major Companies 2017

Table Global Estrogen and Progesterone Revenue (Million USD) by Major Companies (2012-2017)

Table Global Estrogen and Progesterone Revenue Market Share by Major Companies (2012-2017)

Figure Global Estrogen and Progesterone Revenue Market Share by Major Companies 2016

Figure Global Estrogen and Progesterone Revenue Market Share by Major Companies 2017

Table Global Top Companies Key Product Model and Market Performance

Table Global Top Companies Key Target Consumers and Market Performance

Table United States Estrogen and Progesterone Sales Volume () by Top Companies (2012-2017)

Table United States Estrogen and Progesterone Sales Volume Market Share by Top Companies (2012-2017)

Figure United States Estrogen and Progesterone Sales Volume Market Share by Top Companies 2016

Figure United States Estrogen and Progesterone Sales Volume Market Share by Top Companies 2017

Table United States Estrogen and Progesterone Revenue (Million USD) by Top Companies (2012-2017)

Table United States Estrogen and Progesterone Revenue Market Share by Top Companies (2012-2017)

Figure United States Estrogen and Progesterone Revenue Market Share by Top Companies 2016

Figure United States Estrogen and Progesterone Revenue Market Share by Top Companies 2017

Table United States Top Companies Key Product Model and Market Performance

Table United States Top Companies Key Target Consumers and Market Performance

Table Global Estrogen and Progesterone Sales () by Consumer (2012-2017)

Figure Global Estrogen and Progesterone Sales Market Share by Consumer (2012-2017)

Figure Global Estrogen and Progesterone Sales Market Share by Consumer in 2016

Table United States Estrogen and Progesterone Sales () by Consumer (2012-2017)

Figure United States Estrogen and Progesterone Sales Market Share by Consumer (2012-2017)

Figure United States Estrogen and Progesterone Sales Market Share by Consumer in 2016

Table Gedeon Richter Plc. Company Details and Competitors

Table Gedeon Richter Plc. Key Estrogen and Progesterone Models and Performance

Table Gedeon Richter Plc. Estrogen and Progesterone Business SWOT Analysis and Forecast

Table Gedeon Richter Plc. Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Gedeon Richter Plc. Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure Gedeon Richter Plc. Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure Gedeon Richter Plc. Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure Gedeon Richter Plc. Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table Bayer Oy Company Details and Competitors

Table Bayer Oy Key Estrogen and Progesterone Models and Performance

Table Bayer Oy Estrogen and Progesterone Business SWOT Analysis and Forecast

Table Bayer Oy Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Bayer Oy Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure Bayer Oy Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure Bayer Oy Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure Bayer Oy Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table N.V.Organon Company Details and Competitors

Table N.V.Organon Key Estrogen and Progesterone Models and Performance

Table N.V.Organon Estrogen and Progesterone Business SWOT Analysis and Forecast

Table N.V.Organon Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure N.V.Organon Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure N.V.Organon Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure N.V.Organon Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure N.V.Organon Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table Pfizer Healthcare Ireland Company Details and Competitors

Table Pfizer Healthcare Ireland Key Estrogen and Progesterone Models and Performance

Table Pfizer Healthcare Ireland Estrogen and Progesterone Business SWOT Analysis and Forecast

Table Pfizer Healthcare Ireland Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Pfizer Healthcare Ireland Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure Pfizer Healthcare Ireland Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure Pfizer Healthcare Ireland Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure Pfizer Healthcare Ireland Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table Jenapharm GmbH & Co. KG Company Details and Competitors

Table Jenapharm GmbH & Co. KG Key Estrogen and Progesterone Models and Performance

Table Jenapharm GmbH & Co. KG Estrogen and Progesterone Business SWOT Analysis and Forecast

Table Jenapharm GmbH & Co. KG Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure Jenapharm GmbH & Co. KG Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table Besins Healthcare Benelux Company Details and Competitors

Table Besins Healthcare Benelux Key Estrogen and Progesterone Models and Performance

Table Besins Healthcare Benelux Estrogen and Progesterone Business SWOT Analysis and Forecast

Table Besins Healthcare Benelux Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Besins Healthcare Benelux Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure Besins Healthcare Benelux Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure Besins Healthcare Benelux Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure Besins Healthcare Benelux Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table MERCK SERONO LIMITED Company Details and Competitors

Table MERCK SERONO LIMITED Key Estrogen and Progesterone Models and Performance

Table MERCK SERONO LIMITED Estrogen and Progesterone Business SWOT Analysis and Forecast

Table MERCK SERONO LIMITED Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure MERCK SERONO LIMITED Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure MERCK SERONO LIMITED Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure MERCK SERONO LIMITED Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure MERCK SERONO LIMITED Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table Abbott Healthcare Products B.V. Company Details and Competitors

Table Abbott Healthcare Products B.V. Key Estrogen and Progesterone Models and Performance

Table Abbott Healthcare Products B.V. Estrogen and Progesterone Business SWOT Analysis and Forecast

Table Abbott Healthcare Products B.V. Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure Abbott Healthcare Products B.V. Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table Teva Pharma - Produtos Farmaceuticos,Lda. Company Details and Competitors

Table Teva Pharma - Produtos Farmaceuticos,Lda. Key Estrogen and Progesterone Models and Performance

Table Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Business SWOT Analysis and Forecast

Table Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure Teva Pharma - Produtos Farmaceuticos,Lda. Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table Aspen Pharmacare Australia Pty Ltd. Company Details and Competitors

Table Aspen Pharmacare Australia Pty Ltd. Key Estrogen and Progesterone Models and Performance

Table Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Business SWOT Analysis and Forecast

Table Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Output (), Revenue (Million USD), Price () and Gross Margin (%)(2012-2017)

Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales (Million Unit) and Growth Rate (%)(2012-2017)

Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales Market Share (%) in Global (2012-2017)

Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Sales Revenue (Million USD) and Growth Rate (%)(2012-2017)

Figure Aspen Pharmacare Australia Pty Ltd. Estrogen and Progesterone Revenue Market Share (%) in Global (2012-2017)

Table Dr.Kade Pharmazeutische Fabrik GmbH Company Details and Competitors

Table F.I.S.-FABBRICA ITALIANA SINTETICI S.p.A. Company Details and Competitors

Table Eli Lilly Nederland B.V Company Details and Competitors

Table Orion Corporation Company Details and Competitors

Table AstraZeneca UK Limited Company Details and Competitors

Table Novartis Pharma Schweiz AG Company Details and Competitors

Figure Global Estrogen and Progesterone Sales () and Growth Rate (%) Forecast (2017-2022)

Figure Global Estrogen and Progesterone Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure Global Estrogen and Progesterone Price () Trend Forecast (2017-2022)

Table Global Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)

Table Global Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Share Forecast by Regions in 2022

Table Global Estrogen and Progesterone Sales () Forecast by Application (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Application (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Application in 2022

Table Global Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)

Figure Global Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Progesterone stimulant in 2022

Table Global Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)

Figure Global Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Antiprogestogen in 2022

Table Global Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)

Figure Global Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Estrogenic stimulant in 2022

Table Global Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)

Figure Global Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Antiestrogen agent in 2022

Table Global Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)

Figure Global Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)

Figure Global Estrogen and Progesterone Sales Volume Market Share Forecast by Aromatase Inhibitor in 2022

Figure United States Estrogen and Progesterone Sales () and Growth Rate (%) Forecast (2017-2022)

Figure United States Estrogen and Progesterone Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Estrogen and Progesterone Price () Trend Forecast (2017-2022)

Table United States Estrogen and Progesterone Sales () Forecast by Regions (2017-2022)

Table United States Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Share Forecast by Regions (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Share Forecast by Regions in 2022

Table United States Estrogen and Progesterone Sales () Forecast by Application (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Application (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Application in 2022

Table United States Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)

Figure United States Estrogen and Progesterone Sales () Forecast by Progesterone stimulant (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Progesterone stimulant in 2022

Table United States Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)

Figure United States Estrogen and Progesterone Sales () Forecast by Antiprogestogen (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Antiprogestogen in 2022

Table United States Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)

Figure United States Estrogen and Progesterone Sales () Forecast by Estrogenic stimulant (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Estrogenic stimulant in 2022

Table United States Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)

Figure United States Estrogen and Progesterone Sales () Forecast by Antiestrogen agent (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Antiestrogen agent in 2022

Table United States Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)

Figure United States Estrogen and Progesterone Sales () Forecast by Aromatase Inhibitor (2017-2022)

Figure United States Estrogen and Progesterone Sales Volume Market Share Forecast by Aromatase Inhibitor in 2022



Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *